BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 29211298)

  • 1. Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study.
    Vaarwerk B; van der Lee JH; Breunis WB; Orbach D; Chisholm JC; Cozic N; Jenney M; van Rijn RR; McHugh K; Gallego S; Glosli H; Devalck C; Gaze MN; Kelsey A; Bergeron C; Stevens MCG; Oberlin O; Minard-Colin V; Merks JHM
    Cancer; 2018 Mar; 124(5):1016-1024. PubMed ID: 29211298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ
    JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary Rhabdomyosarcoma in Pediatric Patients: A Systematic Review and Meta-Analysis of Individual Patient Data.
    Fuchs J; Murtha-Lemekhova A; Kessler M; Günther P; Fichtner A; Pfeiffenberger J; Probst P; Hoffmann K
    Front Oncol; 2021; 11():701400. PubMed ID: 34660271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of clinical efficacy of Chemotherapy for Rhabdomyosarcoma in children.
    Ning Z; Liu X; Qin G; Wei L; Li X; Shen J
    Pak J Med Sci; 2020; 36(5):1069-1074. PubMed ID: 32704291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas.
    Pappo AS; Dirksen U
    J Clin Oncol; 2018 Jan; 36(2):168-179. PubMed ID: 29220292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Cytogenetic Profiles of Rhabdomyosarcoma with Bone Marrow Involvement in Korean Children: A 15-Year Single-Institution Experience.
    Lee DH; Park CJ; Jang S; Cho YU; Seo JJ; Im HJ; Koh KN; Cho KJ; Song JS; Seo EJ
    Ann Lab Med; 2018 Mar; 38(2):132-138. PubMed ID: 29214757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial.
    Bisogno G; Jenney M; Bergeron C; Gallego Melcón S; Ferrari A; Oberlin O; Carli M; Stevens M; Kelsey A; De Paoli A; Gaze MN; Martelli H; Devalck C; Merks JH; Ben-Arush M; Glosli H; Chisholm J; Orbach D; Minard-Colin V; De Salvo GL;
    Lancet Oncol; 2018 Aug; 19(8):1061-1071. PubMed ID: 29941280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT and MR imaging features of soft tissue rhabdoid tumor: compared with rhabdomyosarcoma in children.
    Sheng J; Li TT; Zhang HH; Xu HF; Cai XM; Xu R; Ji QQ; Wu YM; Huang T; Yang XJ
    Front Pediatr; 2023; 11():1199444. PubMed ID: 37547104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium Supplementation May Not Be Protective against Carboplatin-Induced Nephrotoxicity But May Be Beneficial for Children Suffering Malignancies: A Randomized Clinical Trial.
    Alizadeh Hadadhania M; Ghaffari K; Absalan A; Eghbali A; Rahimi Afzal R; Ghasemi A; Eghbali A
    Adv Biomed Res; 2023; 12():11. PubMed ID: 36926429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological considerations on segmenting rhabdomyosarcoma with diffusion-weighted imaging-What can we do better?
    Chatziantoniou C; Schoot RA; van Ewijk R; van Rijn RR; Ter Horst SAJ; Merks JHM; Leemans A; De Luca A
    Insights Imaging; 2023 Jan; 14(1):19. PubMed ID: 36720720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developments in the Surgical Approach to Staging and Resection of Rhabdomyosarcoma.
    Terwisscha van Scheltinga S; Rogers T; Smeulders N; deCorti F; Guerin F; Craigie R; Burrieza GG; Smeele L; Hol M; van Rijn R; Fuchs J; Seitz G; Schmidt A; Timmermann B; Tunn PU; Chargari C; Dávila Fajardo R; Slater O; Gains J; Merks H
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of functional and metabolic tumor volume using voxel-wise analysis in childhood rhabdomyosarcoma.
    Maennlin S; Chaika M; Gassenmaier S; Grimm R; Sparber-Sauer M; Fuchs J; Schmidt A; Ebinger M; Hettmer S; Gatidids S; Dittmann H; Schäfer JF
    Pediatr Radiol; 2023 Mar; 53(3):438-449. PubMed ID: 36399161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of pediatric extremity soft tissue tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
    Acord MR; Pace E; El-Ali A; Chaturvedi A; Iyer RS; Navarro OM; Pandit-Taskar N; K Parikh A; Schechter A; Shaikh R; McCarville MB
    Pediatr Blood Cancer; 2023 Jun; 70 Suppl 4(Suppl 4):e29944. PubMed ID: 36070194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyosarcoma in children: Retrospective analysis from a single tertiary care center in Saudi Arabia.
    Markiz SN; Khan S; Wagley ZB; Viqaruddin MK; Khafaga YM; AlFawaz IA; AlAnazi AE; AlKofide A; Khoja HA; Ali AA
    Cancer Rep (Hoboken); 2023 Jan; 6(1):e1683. PubMed ID: 35942988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to identifying drug resistance mechanisms to clinically relevant treatments in childhood rhabdomyosarcoma.
    Ghilu S; Morton CL; Vaseva AV; Zheng S; Kurmasheva RT; Houghton PJ
    Cancer Drug Resist; 2022; 5(1):80-89. PubMed ID: 35450020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semi-Automatic Volumetric and Standard Three-Dimensional Measurements for Primary Tumor Evaluation and Response to Treatment Assessment in Pediatric Rhabdomyosarcoma.
    Gowin E; Jończyk-Potoczna K; Sosnowska-Sienkiewicz P; Belen Larque A; Kurzawa P; Januszkiewicz-Lewandowska D
    J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European guideline for imaging in paediatric and adolescent rhabdomyosarcoma - joint statement by the European Paediatric Soft Tissue Sarcoma Study Group, the Cooperative Weichteilsarkom Studiengruppe and the Oncology Task Force of the European Society of Paediatric Radiology.
    van Ewijk R; Schoot RA; Sparber-Sauer M; Ter Horst SAJ; Jehanno N; Borgwardt L; de Keizer B; Merks JHM; de Luca A; McHugh K; von Kalle T; Schäfer JF; van Rijn RR;
    Pediatr Radiol; 2021 Sep; 51(10):1940-1951. PubMed ID: 34137936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Value of Early Tumor Size Response to Chemotherapy in Pediatric Rhabdomyosarcoma.
    van Ewijk R; Vaarwerk B; Breunis WB; Schoot RA; Ter Horst SAJ; van Rijn RR; van der Lee JH; Merks JHM
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33561094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Rhabdomyosarcomas: Three-Dimensional Radiological Assessments after Induction Chemotherapy Predict Survival Better than One-Dimensional and Two-Dimensional Measurements.
    Orsatti G; Morosi C; Giraudo C; Varotto A; Crimì F; Bonzini M; Minotti M; Frigo AC; Zanetti I; Chiaravalli S; Casanova M; Ferrari A; Bisogno G; Stramare R
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic response as assessed by
    Harrison DJ; Chi YY; Tian J; Hingorani P; Mascarenhas L; McCowage GB; Weigel BJ; Venkatramani R; Wolden SL; Yock TI; Rodeberg DA; Hayes-Jordan AA; Teot LA; Spunt SL; Meyer WH; Hawkins DS; Shulkin BL; Parisi MT
    Cancer Med; 2021 Feb; 10(3):857-866. PubMed ID: 33340280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.